These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 25636967)

  • 21. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5.
    Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
    Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation.
    Sodi VL; Bacigalupa ZA; Ferrer CM; Lee JV; Gocal WA; Mukhopadhyay D; Wellen KE; Ivan M; Reginato MJ
    Oncogene; 2018 Feb; 37(7):924-934. PubMed ID: 29059153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
    Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
    Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
    J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.
    Trinca GM; Goodman ML; Papachristou EK; D'Santos CS; Chalise P; Madan R; Slawson C; Hagan CR
    Horm Cancer; 2018 Feb; 9(1):12-21. PubMed ID: 28929346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parallel study on protein O-GlcNAcylation in prostate cancer cell with a sensitive microarray biochip.
    Lei L; Xie J; Yu J; Li Y; Liu Y
    Anal Biochem; 2018 Oct; 558():53-59. PubMed ID: 30086259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.
    Efimova EV; Appelbe OK; Ricco N; Lee SS; Liu Y; Wolfgeher DJ; Collins TN; Flor AC; Ramamurthy A; Warrington S; Bindokas VP; Kron SJ
    Mol Cancer Res; 2019 Jun; 17(6):1338-1350. PubMed ID: 30885991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-GlcNAcylation modulates HBV replication through regulating cellular autophagy at multiple levels.
    Wang X; Lin Y; Liu S; Zhu Y; Lu K; Broering R; Lu M
    FASEB J; 2020 Nov; 34(11):14473-14489. PubMed ID: 32892442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
    Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
    Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of mTOR affects protein stability of OGT.
    Park S; Pak J; Jang I; Cho JW
    Biochem Biophys Res Commun; 2014 Oct; 453(2):208-12. PubMed ID: 24858682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers.
    Spaner DE
    Front Immunol; 2021; 12():772304. PubMed ID: 34868034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.
    Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H
    Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
    Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate mammalian target of rapamycin inhibition induces autophagy in HTR8/SVneo cells via O-linked β-N-acetylglucosamine signaling.
    Zhang Q; Na Q; Song W
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1585-1596. PubMed ID: 28691313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer.
    Champattanachai V; Netsirisawan P; Chaiyawat P; Phueaouan T; Charoenwattanasatien R; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J
    Proteomics; 2013 Jul; 13(14):2088-99. PubMed ID: 23576270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
    Barkovskaya A; Seip K; Hilmarsdottir B; Maelandsmo GM; Moestue SA; Itkonen HM
    Sci Rep; 2019 Apr; 9(1):5670. PubMed ID: 30952976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
    Jang TJ; Kim UJ
    Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy.
    Mi W; Gu Y; Han C; Liu H; Fan Q; Zhang X; Cong Q; Yu W
    Biochim Biophys Acta; 2011 Apr; 1812(4):514-9. PubMed ID: 21255644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.